European Journal of Cancer
Volume 46, Issue 13 , Pages 2389-2398 , September 2010

Trends in G-CSF use in 990 patients after EORTC and ASCO guidelines

  • C. Falandry

      Affiliations

    • Medical Oncology Unit, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, Université Lyon 1, Lyon, France
    • Corresponding Author InformationCorresponding author at: Medical Oncology Unit, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Bénite cedex, France. Tel.: +33 478864318; fax: +33 478864319.
    • ,
  • M. Campone

      Affiliations

    • Institut Régional du Cancer Nantes Atlantique, CLCC René Gauducheau, Centre de Recherche en Cancérologie, INSERM 892, Nantes, Saint Herblain, France
    • ,
  • G. Cartron

      Affiliations

    • Hematology Department, CHU Montpellier, UMR-CNRS5235, Université Montpellier, Montpellier, France
    • ,
  • D. Guerin

      Affiliations

    • A+A Healthcare Marketing Research, Lyon, France
    • ,
  • G. Freyer

      Affiliations

    • Medical Oncology Unit, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, Université Lyon 1, Lyon, France

Received 6 February 2010 ,Revised 26 April 2010 ,Accepted 29 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(10)00372-2

doi: 10.1016/j.ejca.2010.04.031

European Journal of Cancer
Volume 46, Issue 13 , Pages 2389-2398 , September 2010

Article Tools

* Image Usage & Resolution